Form 4: Nu Skin Director Thomas Pisano Acquires 18,008 Shares of Class A Common Stock
Insider Transaction Report
Nu Skin Enterprises, Inc. Director Thomas R. Pisano reported the acquisition of 18,008 shares of Class A Common Stock on June 2, 2025, increasing his total beneficial ownership to 90,184 shares.
Summary
- Thomas R. Pisano, a Director of Nu Skin Enterprises, Inc. (NUS), acquired 18,008 shares of the company's Class A Common Stock.
- The transaction occurred on June 2, 2025, and the shares were acquired at a price of $0.00 per share, typically indicating a grant or award rather than a cash purchase.
- Following this acquisition, Mr. Pisano's direct beneficial ownership of Class A Common Stock increased to 90,184 shares.
- The Form 4 filing was signed by Gregory Belliston as Attorney-in-Fact for Thomas R. Pisano on June 3, 2025, under a Limited Power of Attorney dated April 27, 2025.
Sentiment
Score: 7
Explanation: The acquisition of shares by a director, even if a grant, generally indicates alignment of interests and potential confidence in the company, which is a positive signal. There are no negative implications from this specific filing.
Positives
- An insider, Director Thomas R. Pisano, increased his beneficial ownership in the company by acquiring 18,008 shares, which can be viewed as a sign of confidence in the company's future prospects.
- The acquisition at $0.00 per share suggests a grant or award, likely as part of compensation or a long-term incentive plan, which aligns management's interests with those of shareholders.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This Form 4 filing is a routine disclosure of insider stock ownership changes and does not provide broader industry context or trends. Insider acquisitions, especially through grants, are common across various industries as part of executive compensation and incentive programs.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | Thomas R. Pisano granted a Limited Power of Attorney to several individuals, including Gregory Belliston, to handle his SEC reporting obligations (Forms 3, 4, 5, and 144). | 04/27/2025 | This is a standard corporate governance practice to ensure timely and accurate insider trading compliance filings for directors and officers. |
Stakeholder Impact
- Shareholders: The acquisition of shares by a director may be perceived positively, signaling management's belief in the company's value and future prospects.
- Management/Employees: The grant of shares to a director aligns their financial interests with the long-term performance of the company, potentially incentivizing strong performance.
Key Dates
| Date | Description |
|---|---|
| 04/27/2025 | Date Thomas R. Pisano executed a Limited Power of Attorney for SEC reporting purposes. |
| 06/02/2025 | Date of the reported transaction where Thomas R. Pisano acquired shares of Class A Common Stock. |
| 06/03/2025 | Date the Form 4 filing was signed by the Attorney-in-Fact. |
Keywords
Nu Skin Enterprises, NUS, Form 4, Insider Trading, Stock Acquisition, Director, Thomas R. Pisano, Beneficial Ownership, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.